Silibinin attenuates oxidative metabolism and cytokine production by monocytes from preeclamptic women

References

• Walker JJ. Pre-eclampsia. Lancet 2000;356:1260–1265.
   PubMed Web of Science ®Google Scholar
• Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785–799.
   PubMed Web of Science ®Google Scholar
• Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation 2002;9:147–160.
   PubMed Web of Science ®Google Scholar
• Borzychowski AM, Sargent IL, Redman CW. Inflammation and pre-eclampsia. Semin Fetal Neonatal Med 2006;11:309–316.
   PubMed Web of Science ®Google Scholar
• Lok CA, Jebbink J, Nieuwland R, Faas MM, Boer K, Sturk A, Van Der Post JA. Leukocyte activation and circulating leukocyte-derived microparticles in preeclampsia. Am J Reprod Immunol 2009;61:346–359.
   PubMed Web of Science ®Google Scholar
• Köksal E, Gülçin I, Beyza S, Sarikaya O, Bursal E. In vitro antioxidant activity of silymarin. J Enzyme Inhib Med Chem 2009;24:395–405.
   PubMed Web of Science ®Google Scholar
• Abenavoli L, Capasso R, Milic N, Capasso F. Milk thistle in liver diseases: past, present, future. Phytother Res 2010;24: 1423–1432.
   PubMed Web of Science ®Google Scholar
• Tyagi A, Singh RP, Ramasamy K, Raina K, Redente EF, Dwyer-Nield LD, . Growth inhibition and regression of lung tumors by silibinin: modulation of angiogenesis by macrophage-associated cytokines and nuclear factor-kappaB and signal transducers and activators of transcription 3. Cancer Prev Res (Phila) 2009;2:74–83.
   PubMed Web of Science ®Google Scholar
• Bannwart CF, Nakaira-Takahagi E, Golim MA, de Medeiros LT, Romão M, Weel IC, Peraçoli MT. Downregulation of nuclear factor-kappa B (NF-kappaB) pathway by silibinin in human monocytes challenged with Paracoccidioides brasiliensis. Life Sci 2010;86:880–886.
   PubMed Web of Science ®Google Scholar
• Bannwart CF, Peraçoli JC, Nakaira-Takahagi E, Peraçoli MT. Inhibitory effect of silibinin on tumour necrosis factor-alpha and hydrogen peroxide production by human monocytes. Nat Prod Res 2010;24:1747–1757.
   PubMed Web of Science ®Google Scholar
• Bremner P, Heinrich M. Natural products as targeted modulators of the nuclear factor-KB pathway. J Pharm Pharmacol 2002;54:453–472.
   PubMed Web of Science ®Google Scholar
• Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 2007;117: 1175–1183.
   PubMed Web of Science ®Google Scholar
• Manna SK, Mukhopadhyay A, Van NT, Aggarwal BB. Silymarin suppress TNF-induced activation of NF-kB, c-Jun N-terminal kinase, and apoptosis. J Immunol 1999;163:6800–6809.
   PubMed Web of Science ®Google Scholar
• Giorgi VS, Peracoli MT, Peracoli JC, Witkin SS, Bannwart-Castro CF. Silibinin modulates the NF-κb pathway and pro-inflammatory cytokine production by mononuclear cells from preeclamptic women. J Reprod Immunol 2012;95:67–72.
   PubMed Web of Science ®Google Scholar
• Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, . Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?Hypertension 2003;41: 1183–1190.
   PubMed Web of Science ®Google Scholar
• Falasca K, Ucciferri C, Mancino P, Vitacolonna E, De Tullio D, Pizzigallo E, . Treatment with silybin-vitamin E-phospholipid complex in patients with hepatitis C infection. J Med Virol 2008;80:1900–1906.
   PubMedGoogle Scholar
• Ferenci P, Dragosics B, Dittrich H, Frank H, Benda L, Lochs H, . Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol 1989;9:105–113.
   PubMed Web of Science ®Google Scholar
• Luppi P, Deloia JA. Monocytes of preeclamptic women spontaneously synthesize pro-inflammatory cytokines. Clin Immunol 2006;118:268–275.
   PubMed Web of Science ®Google Scholar
• Peraçoli JC, Rudge MV, Peraçoli MT. Tumor necrosis factor-alpha in gestation and puerperium of women with gestational hypertension and pre-eclampsia. Am J Reprod Immunol 2007;57:177–185.
   PubMed Web of Science ®Google Scholar
• Kalinderis M, Papanikolaou A, Kalinderi K, Ioannidou E, Giannoulis C, Karagiannis V, Tarlatzis BC. Elevated serum levels of interleukin-6, interleukin-1β and human chorionic gonadotropin in pre-eclampsia. Am J Reprod Immunol 2011; 66:468–475.
   PubMed Web of Science ®Google Scholar
• Ouyang YQ, Li SJ, Zhang Q, Cai HB, Chen HP. Interactions between inflammatory and oxidative stress in preeclampsia. Hypertens Pregnancy 2009;28:56–62.
   PubMed Web of Science ®Google Scholar
• Peraçoli MT, Bannwart CF, Cristofalo R, Borges VT, Costa RA, Witkin SS, Peraçoli JC. Increased reactive oxygen species and tumor necrosis factor-alpha production by monocytes are associated with elevated levels of uric acid in pre-eclamptic women. Am J Reprod Immunol 2011;66:460–467.
   PubMed Web of Science ®Google Scholar
• Comelli MC, Mengs U, Schneider C, Prosdocimi M. Toward the definition of the mechanism of action of silymarin: activities related to cellular protection from toxic damage induced by chemotherapy. Integr Cancer Ther 2007;6:120–129.
   PubMed Web of Science ®Google Scholar
• National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report of National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1–S22.
   PubMed Web of Science ®Google Scholar
• Russo M, Teixeira HC, Marcondes MC, Barbuto JA. Superoxide-independent hydrogen peroxide release by activated macrophages. Braz J Med Biol Res 1989;22:1271–1273.
   PubMed Web of Science ®Google Scholar
• Saito S, Shiozaki A, Nakashima A, Sakai M, Sasaki Y. The role of the immune system in preeclampsia. Mol Aspects Med 2007;28:192–209.
   PubMed Web of Science ®Google Scholar
• Germain SJ, Sacks GP, Soorana SR, Sargent IL, Redman CW. Systemic inflammatory priming in normal pregnancy and preeclampsia: The role of circulating syncytiotrophoblast microparticles. J Immunol 2007;178:5949–5956.
   PubMed Web of Science ®Google Scholar
• Van der Post JA, Lok CA, Boer K, Sturk A, Sargent IL, Nieuwland R. The functions of microparticles in pre-eclampsia. Semin Thromb Hemost 2011;37:146–152.
   PubMed Web of Science ®Google Scholar
• Aris A, Benali S, Ouellet A, Moutquin JM, Leblanc S. Potential biomarkers of preeclampsia: inverse correlation between hydrogen peroxide and nitric oxide early in maternal circulation and at term in placenta of women with preeclampsia. Placenta 2009;30:342–347.
   PubMed Web of Science ®Google Scholar
• Kharb S, Gulati N, Singh V, Singh GP. Superoxide anion formation and glutathione levels in patients with preeclampsia. Gynecol Obstet Invest 2000;49:28–30.
   PubMed Web of Science ®Google Scholar
• Takagi Y, Nikaido T, Toki T, Kita N, Kanai M, Ashida T, . Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction. Virchows Arch 2004;444:49–55.
   PubMed Web of Science ®Google Scholar
• Sacks GP, Studena K, Sargent IL, Redman CWG. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 1998;179:80–86.
   PubMed Web of Science ®Google Scholar
• Tsukimori K, Tsushima A, Fukushima K, Nakano H, Wake N. Neutrophil-derived reactive oxygen species can modulate neutrophil adhesion to endothelial cells in preeclampsia. Am J Hypertens 2008;21:587–591.
   PubMedGoogle Scholar
• Varga Z, Czompa A, Kakuk G, Antus S. Inhibition of the superoxide anion release and hydrogen peroxide formation in PMNLs by flavonolignans. Phytother Res 2001;15: 608–612.
   PubMed Web of Science ®Google Scholar
• Beckmann I, Efraim SB, Vervoort M, Visser W, Wallenburg HC. Tumor necrosis factor-alpha in whole blood cultures of preeclamptic patients and healthy pregnant and nonpregnant women. Hypertens Pregnancy 2004;23:319–329.
   PubMed Web of Science ®Google Scholar
• Khan F, Belch JJ, MacLeod M, Mires G. Changes in endothelial function precede the clinical disease in women in whom preeclampsia develops. Hypertension 2005;46:1123–1128.
   PubMed Web of Science ®Google Scholar
• Schümann J, Prockl J, Kiemer AK, Vollmar AM, Bang R, Tiegs G. Silibinin protects mice from T cell-dependent liver injury. J Hepatol 2003;39:333–340.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Agarwal C, Ichikawa H, Singh RP, Aggarwal BB. Anticancer potential of silymarin: from bench to bed side. Anticancer Res 2006;26:4457–4498.
   PubMed Web of Science ®Google Scholar
• Brewster JA, Orsi NM, Gopichandran N, McShane P, Ekbote UV, Walker JJ. Gestational effects on host inflammatory response in normal and pre-eclamptic pregnancies. Eur J Obstet Gynecol Reprod Biol 2008;140:21–26.
   PubMed Web of Science ®Google Scholar
• Jonsson Y, Rubèr M, Matthiesen L, Berg G, Nieminen K, Sharma S, . Cytokine mapping of sera from women with pré-eclâmpsia and normal pregnancies. J Reprod Immunol 2006;70:83–91.
   PubMed Web of Science ®Google Scholar
• Luppi P, Tse H, Lain KY, Markovic N, Piganelli JD, DeLoia JA. Preeclampsia activates circulating immune cells with engagement of the NF-kappaB pathway. Am J Reprod Immunol 2006;56:135–144.
   PubMed Web of Science ®Google Scholar
• Sharma A, Satyam A, Sharma JB. Leptin, IL-10 and inflammatory markers (TNF-alpha, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant women. Am J Reprod Immunol 2007;58:21–30.
   PubMed Web of Science ®Google Scholar
• Sakai M, Tsuda H, Tanebe K, Sasaki Y, Saito S. Interleukin-12 secretion by peripheral blood mononuclear cells is decreased in normal pregnant subjects and increased in preeclamptic patients. Am J Reprod Immunol 2002;47:91–97.
   PubMed Web of Science ®Google Scholar
• Mansouri R, Akbari F, Vodjgani M, Mahboudi F, Kalantar F, Mirahmadian M. Serum cytokines profiles in Iranian patients with preeclampsia. Iran J Immunol 2007;4:179–185.
   PubMedGoogle Scholar
• Arikan DC, Aral M, Coskun A, Ozer A. Plasma IL-4, IL-8, IL-12, interferon-γ and CRP levels in pregnant women with preeclampsia, and their relation with severity of disease and fetal birth weight. J Matern Fetal Neonatal Med 2012; doi:10.3109/14767058.2011.648233.
   Google Scholar
• Dudley DJ, Hunter C, Mitchell MD, Varner MW, Gately M. Elevations of serum interleukin-12 concentrations in women with severe pre-eclampsia and HELLP syndrome. J Reprod Immunol 1996;31:97–107.
   PubMed Web of Science ®Google Scholar
• Hayashi M, Hamada Y, Ohkura T. Elevation of granulocyte-macrophage colony-stimulating factor in the placenta and blood in preeclampsia. Am J Obstet Gynecol 2004;190:456–461.
   PubMed Web of Science ®Google Scholar
• Azizieh F, Raghupathy R, Makhseed M. Maternal cytokine production patterns in women with pre-eclampsia. Am J Reprod Immunol 2005;54:30–37.
   PubMed Web of Science ®Google Scholar
• Hanna N, Hanna I, Hleb M, Wagner E, Dougherty J, Balkundi D, . Gestational age-dependent expression of interleukin-10 and its receptor in human placental tissues and isolated cytotrophoblasts. J Immunol 2000;164:5721–5728.
   PubMed Web of Science ®Google Scholar
• Kang JS, Jeon YJ, Kim HM, Han SH, Yang KH. Inhibition of inducible nitric-oxide synthase expression by silymarin in lipopolysaccharide-stimulated macrophages. J Pharmacol Exp Ther 2002;302:138–144.
   PubMed Web of Science ®Google Scholar
• Pradhan SC, Girish C. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Indian J Med Res 2006;124:491–504.
   PubMed Web of Science ®Google Scholar
• Polyak SJ, Morishima C, Shuhart MC, Wang CC, Liu Y, Lee DY: Inhibition of T-cell inflammatory cytokines, hepatocyte NF-kappaB signaling, and HCV infection by standardized Silymarin. Gastroenterology 2007;132:1925–1936.
   PubMed Web of Science ®Google Scholar
• Saller R, Brignoli R, Melzer J, Meier R. An updated systematic review with meta-analysis for the clinical evidence of silymarin. Forsch Komplementmed 2008;15:9–20.
   PubMedGoogle Scholar